Pauric Bannigan, Intrepid Labs, explains how physics-informed machine learning aids formulation and why regulators still want experimental data.
News|Articles|July 1, 2002
- Pharmaceutical Technology-07-02-2002
- Volume 26
- Issue 7
Novel Approaches for Topical Delivery of Acetazolamide
Author(s)Anil K. Singla, PhD
Extensive research has been conducted to improve the solubility and permeability of acetazolamide in hopes that a topical formulation for the treatment of glaucoma can be developed.
Advertisement
Articles in this issue
over 24 years ago
Congress Adopts New User Fee Programover 24 years ago
Validation Basics: A System Developer's Approach to Validationover 24 years ago
How to Engage in a Strategic Outsourcing Relationshipover 24 years ago
Outsourcing Outlookover 24 years ago
Electrodeionization in Pharmaceutical Water TreatmentAdvertisement
Related to this article
Pauric Bannigan, Intrepid Labs, explains where AI speeds formulation decisions, why data is the bottleneck, and how active learning trains models with far less data.
Stephanie Johnson, Pfizer, explains how off-platform triggers, single-owner risk registers, and traceable prior knowledge keep protein formulation programs on track.
Stephanie Johnson, Pfizer, discusses how platform formulations moved 2 Pfizer protein programs to IND in 8 months by redistributing, not removing risk.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Advertisement
Advertisement